Alex Nolte

Alex Nolte is the Interim Head of Finance of Allievex Corporation. Mr. Nolte has over a decade of finance experience in fast-growing companies within the biopharmaceutical industry. Next to his role at Allievex, Mr. Nolte is also VP of Corporate Finance at Syndax Pharmaceuticals, Inc. Prior to joining Syndax, he served in various roles of increasing responsibility, culminating in the position of Corporate Controller of CoLucid Pharmaceuticals, Inc. He also served as a Director of Revenue Recognition and International Controller at Aegerion Pharmaceuticals, Inc. and in various positions at Genzyme Corporation.

Mr. Nolte began his professional career at KPMG Accountants NV in the Netherlands and PricewaterhouseCoopers LLP in Boston, Massachusetts. Mr. Nolte received his B.S. in Accountancy, from The Hague University (the Netherlands) and is a licensed Certified Public Accountant in the State of Massachusetts.